2024³â ´ëÇѸ鿪ÇÐȸ 50Áֳ⠱â³ä Ãá°èÇмú´ëȸ 3ÀÏÂ÷ : 2024-04-13
±³À°ÀÏÀÚ : 2024-04-13
±³À°Àå¼Ò : ¿©¼ö ¿¢½ºÆ÷ ÄÁº¥¼Ç¼¾ÅÍ ¿¢½ºÆ÷Ȧ ¹× ±×·£µåȦ
±³À°ÁÖÁ¦ : 2024³â ´ëÇѸ鿪ÇÐȸ 50Áֳ⠱â³ä Ãá°èÇмú´ëȸ 3ÀÏÂ÷
ÁÖÃÖ±â°ü : ´ëÇѸ鿪ÇÐȸ
´ã´çÀÚ : ±èÁÖ¿¬
¿¬¶ôó : 02-2038-8555
À̸ÞÀÏ : kai@kaimm.org
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤½Å°Ç°ÀÇÇаú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, ¼ºÇü¿Ü°ú, ¾È°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, »ê¾÷ÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаú, ÀÇ»çÇÐ, ¹ýÀÇÇÐ, ¿¹¹æÀÇÇÐ, ÇغÎÇÐ, »ý¸®ÇÐ, »ýÈÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ±â»ýÃæÇÐ, ¾à¸®ÇÐ, ÀÇÇб³À°, ±âŸ
Âü¼®¿¹»óÀÎ : 900¸í
Èñ¸ÁÆòÁ¡ : 2Á¡
Áö¿ª : Àü¶ó³²µµ
±³À°½Ã°£ : 2 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 280,000¿ø
ºñ°í "»çÀüµî·Ï
Çлýȸ¿ø 10¸¸¿ø, ȸ¿ø 14¸¸¿ø, ºñȸ¿ø 25¸¸¿ø
ÇöÀåµî·Ï
Çлýȸ¿ø 13¸¸¿ø, ȸ¿ø 17¸¸¿ø, ºñȸ¿ø 28¸¸¿ø"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 13ÀÏ Room A (¿¢½ºÆ÷Ȧ) 08:50~09:10 Harnessing non-invasive immune cell characterization in lung cancer patients. ·ùÈñÁÖ(¼º±Õ°ü´ë)
±³À°½Ã°£ 04¿ù 13ÀÏ Room A (¿¢½ºÆ÷Ȧ) 09:10~09:30 Cytokine (IL-2)-independent role of IL2RA (CD25) in B-cell homeostasis ÀÌÀç¿õ(°í·Á´ë)
±³À°½Ã°£ 04¿ù 13ÀÏ Room A (¿¢½ºÆ÷Ȧ) 09:30~09:50 Understanding Interactions of Microbe-Epithelia-Immune System Àå°æ±¸(¿¬¼¼´ë)
±³À°½Ã°£ 04¿ù 13ÀÏ Room A (¿¢½ºÆ÷Ȧ) 09:50~10:10 Discovery of Innate immune modulator in the PANoptosis and Cytokine strorm ÇÑÁÖÈñ(¿ì¼®´ë)
ÈÞ½Ä 04¿ù 13ÀÏ 10:10~10:40 ÈÞ½Ä ()
±³À°½Ã°£ 04¿ù 13ÀÏ Room A (¿¢½ºÆ÷Ȧ) 10:40~11:00 Immunosurveillance of the Central Nervous System by Dural Macrophages ±è¿µÂù(¼¿ï´ë)
±³À°½Ã°£ 04¿ù 13ÀÏ Room A (¿¢½ºÆ÷Ȧ) 11:00~11:20 Application of single cell RNA sequencing in the clinical diseases ÀÌ»óÁø(°æºÏ´ë)
±³À°½Ã°£ 04¿ù 13ÀÏ Room A (¿¢½ºÆ÷Ȧ) 11:20~11:40 Epigenetic scars in immune cells during inflammatory diseases °íÁØ¿µ(Áö³ðÀλçÀÌÆ®)
±³À°½Ã°£ 04¿ù 13ÀÏ Room A (¿¢½ºÆ÷Ȧ) 11:40~12:00 Strategies to promote cellular immunotherapy outcome in multiple myeloma Á¶Çö¼ö(¿¬¼¼´ë)